Today

Agents

Chat

Arena

Discover

More

App

Haemonetics adds Carlyle operating executive Martin Madaus to board - HAE News | Rallies

Haemonetics adds Carlyle operating executive Martin Madaus to board

HAE•2026-07-28

Board appointment

Haemonetics elected Martin Madaus to its board, effective July 24, 2026.
Madaus is a senior operating executive at Carlyle, advising healthcare investments since 2019.
He previously led Ortho Clinical Diagnostics as chairman and CEO, running its turnaround following the Johnson & Johnson carve-out.
Earlier roles include chairman, president and CEO of Millipore through its 2010 sale to Merck KGaA.

Related News

Sound Financial Bancorp Q2 profit rises on loan yields, prepayment fee

SFBC•2026-07-28

Canada's Boardwalk REIT Q2 FFO per unit rises

XLRE•2026-07-28

Gran Tierra Energy updates financial calendar for second-quarter results release and conference call

Sources

S

Haemonetics adds Carlyle operating executive Martin Madaus to board

Sec

•

2026-07-28

Summit State Bank turns to Q2 FY26 net loss of $1.31 million; net interest margin widens 0.29 percentage point to 3.95%

SSBI•2026-07-28

First Commonwealth Financial Q2 Adjusted EPS USD 0.44 Vs. IBES Estimate USD 0.42

FCF•2026-07-28